Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

X5 Retail Group reported for 6 months of 2024 by IFRS

8/15/24 X5

Delimobile opened new service stations

8/15/24 DELI

Sovcombank reported for 6 months of 2024 by IFRS

8/15/24 SVCB

Softline acquires control in one of Gazprombank's IT divisions

8/15/24 SOFL

Softline reported for 6 months of 2024 by IFRS

8/15/24 SOFL

VTB to join Post Bank in 2026

8/14/24 VTBR

Slavneft-Megionneftegaz reported for 6M 2024 by RAS

8/14/24 MFGS

Moscow Exchange resumes trading on the stock market

8/14/24 MOEX

Trading on the stock market has been suspended

8/14/24 MOEX

Fesco launches regular sea line between Vietnam and Malaysia

8/14/24 FESH